A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study - Park, W; Hrycaj, P; Jeka, S (Ann Rheum Dis, 2013)
et al